Benzimidazoles
Cayman Chemical Albendazole sulfon 25mg
An active metabolite of albendazole; inhibits spore formation of E. hellem, E. cuniculi, and E. intestinalis in vitro (IC90s = <0.0001, <0.001, and <0.1 UG/ml, respectively)
Medchemexpress LLC Fenbendazole | 43210-67-9 | 99.9% | 1 ML
Fenbendazole | 43210-67-9 | 99.9% | 1 ML
Medchemexpress LLC Omeprazole (Standard) | 73590-58-6 | 99.9% | C17H19N3O3S | 50 MG
Omeprazole (Standard) is an analytical reference standard and a proton pump inhibitor (PPI) used for acid-related gastrointestinal disorders. This product is designed for research, inhibiting CYP2C19 activity (Ki 2-6 μM) and the growth of Gram-positive and Gram-negative bacteria. It also acts as a potent brain-penetrant neutral sphingomyelinase (N-SMase) and exosome inhibitor.
- Analytical standard for qualitative, quantitative, and methodological research experiments (HPLC, GC, MS).
- Treats acid-related gastrointestinal disorders.
- Competitively inhibits CYP2C19 activity (Ki 2-6 μM).
- Inhibits Gram-positive and Gram-negative bacteria growth.
- Potent brain-penetrant neutral sphingomyelinase (N-SMase) and exosome inhibitor.
- High purity of 99.86%.
- Solid, white to off-white appearance.
Cayman Chemical Omeprazole N-oxide | 176219-04-8 | 25mg
A metabolite of omeprazole; a potential impurity found in commercial preparations of omeprazole
Apexbio Technology LLC Albendazole Oxide 54029-12-8 10mM (in 1mL DMSO)
Albendazole Oxide (CAS 54029-12-8) is a small-molecule inhibitor targeting beta-tubulin It is designed to inhibit beta-tubulin polymerization in parasites thereby disrupting cytoplasmic microtubule structure and interfering with glucose metabolic pathways Albendazole Oxide exerts its biological activity primarily through inhibition of beta-tubulin polymerization In both in vitro and in vivo studies Albendazole Oxide demonstrates anti-parasitic activity with reported IC50 values typically ranging from nanomolar to micromolar concentrations depending on the parasite species and assay system Based on these pharmacological properties Albendazole Oxide holds research potential in the exploration of anti-parasitic pharmacodynamics notably for studies involving Echinococcus spp and other parasitic infections
Medchemexpress LLC Fenbendazole (Standard) | 43210-67-9 | 99.9% | 50 MG
Fenbendazole (Standard) | 43210-67-9 | 99.9% | 50 MG
Medchemexpress LLC Fenbendazole (Standard) | 43210-67-9 | 99.9% | 25 MG
Fenbendazole (Standard) is an analytical standard and orally active benzimidazole anthelmintic agent with a broad antiparasitic range. It functions as a microtubule destabilizing agent, binding to tubulin and disrupting microtubule equilibrium in helminthes. It also stabilizes HIF-1α, shows anti-proliferative activity, induces apoptosis, and causes cell-cycle arrest, with demonstrated antitumor activity in mice xenografted with wild-type p53.
- Analytical standard for research and analytical applications
- Orally active benzimidazole anthelmintic agent
- Broad antiparasitic range
- Microtubule destabilizing agent
- Disrupts tubulin microtubule equilibrium
- Stabilizes HIF-1α
- Exhibits anti-proliferative and antitumor activity
- Induces apoptosis and cell-cycle arrest
- Applied in qualitative, quantitative, and methodological research (HPLC, GC, MS)
Medchemexpress LLC Omeprazole | 73590-58-6 | 99.86% | C17H19N3O3S | 100 MG
Omeprazole (Standard) is an analytical standard intended for research and analytical applications. It serves as a reference standard in qualitative, quantitative, and methodological research experiments, including HPLC, GC, and MS. This compound acts as a proton pump inhibitor (PPI) and can inhibit the growth of Gram-positive and Gram-negative bacteria.
- Reference standard for analytical applications
- Suitable for HPLC, GC, and MS experiments
- Functions as a proton pump inhibitor (PPI)
- Inhibits growth of Gram-positive and Gram-negative bacteria
- Potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor
Medchemexpress LLC (R)-Omeprazole sodium | 161796-77-6 | 98.1% | 100 MG
(R)-Omeprazole sodium is a gastric acid resistant compound that inhibits gastric acid secretion. It is primarily metabolized by cytochrome P450 enzymes in vivo, and its interaction with mannitol may affect its bioavailability in formulations. This compound exhibits reversible direct and metabolism-dependent inhibition of CYP2C19. It is intended for research use only.
- Gastric acid resistant compound
- Inhibits gastric acid secretion
- Metabolism affected by cytochrome P450 enzymes
- May interact with mannitol affecting bioavailability
- Exhibits reversible direct and metabolism-dependent inhibition of CYP2C19
- For research use only
Medchemexpress LLC Omeprazole-d3 | 922731-01-9 | 99.0% | 348.43 g/mol | C17H16D3N3O3S | 10 MG
Omeprazole-d3 is a deuterium-labeled omeprazole supplied as a stable-isotope reference standard for analytical and research applications, especially as an internal standard in LC-MS, pharmacokinetic, and metabolic studies. It is provided as a light brown solid with high chemical purity suitable for quantitative analysis.
- Deuterium-labeled internal standard for LC-MS quantitation.
- High chemical purity (≈99.0%) suitable for analytical applications.
- Solid form with light brown to brown appearance for easy handling.
- Includes CAS number 922731-01-9 for unambiguous identification.
- Stable when stored as powder at -20°C for up to 3 years.
Medchemexpress LLC (R)-Omeprazole sodium | 161796-77-6 | 98.1% | 50 MG
(R)-Omeprazole sodium is a gastric acid resistant compound that inhibits gastric acid secretion. Its metabolism in vivo is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. It exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.
- Gastric acid resistant compound
- Inhibits gastric acid secretion
- Metabolized primarily by cytochrome P450 enzymes
- Interaction with mannitol may affect bioavailability
- Exhibits reversible direct and metabolism-dependent inhibition of CYP2C19
Medchemexpress LLC (R)-Omeprazole (sodium) | 161796-77-6 | 98.1% | 250 MG
(R)-Omeprazole sodium is a gastric acid resistant compound that inhibits gastric acid secretion. It is primarily metabolized in vivo by cytochrome P450 enzymes. Interactions with mannitol may affect its bioavailability in certain formulations.
- Inhibits gastric acid secretion
- Metabolized by cytochrome P450 enzymes
- Interacts with mannitol
- Reversibly inhibits CYP2C19 directly and metabolism-dependently
- For research use only